InsiderClue
Stocks · Health care · Medicinal Chemicals & Botanical Products

MediWound Ltd.

MDWD Clue Score33
Israel Fiscal year ends December CIK 0001593984
$12.54 +0.97% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $12.54 +291.88% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.6Operating income−20.2Net income−18.9Fiscal year 2017Revenue2.5 +60.2%Operating income−13.7Net income−22.1Fiscal year 2018Revenue3.4 +36.3%Operating income−4.0Net income−1.1Fiscal year 2019Revenue31.8 +834.7%Operating income4.5Net income5.0Fiscal year 2020Revenue21.8 −31.5%Operating income−8.8Net income−9.2 −285.6%EPS, diluted−2.38Fiscal year 2021Revenue23.8 +9.2%Operating income−11.2Net income−13.6EPS, diluted−3.48Fiscal year 2022Revenue26.5 +11.5%Operating income−8.3Net income−19.6EPS, diluted−3.93Fiscal year 2023Revenue18.7 −29.5%Operating income−15.3Net income−6.7EPS, diluted−0.75Fiscal year 2024Revenue20.2 +8.2%Operating income−19.4Net income−30.2EPS, diluted−3.03Fiscal year 2025Revenue17.0 −16.1%Operating income−25.3Net income−23.9EPS, diluted−2.10
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.6 2.5 3.4 31.8 21.8 23.8 26.5 18.7 20.2 17.0
Growth +60.2% +36.3% +834.7% −31.5% +9.2% +11.5% −29.5% +8.2% −16.1%
Operating income −20.2 −13.7 −4.0 4.5 −8.8 −11.2 −8.3 −15.3 −19.4 −25.3
Net income −18.9 −22.1 −1.1 5.0 −9.2 −13.6 −19.6 −6.7 −30.2 −23.9
Growth −285.6%
EPS, diluted n/a n/a n/a n/a −2.38 −3.48 −3.93 −0.75 −3.03 −2.10

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin−38.5%Operating margin−1,293.6%Net margin−1,212.1%Free cash flow margin−1,098.6%Fiscal year 2017Gross margin36.8%Operating margin−548.4%Net margin−887.4%Free cash flow margin−701.1%Fiscal year 2018Gross margin38.6%Operating margin−116.4%Net margin−31.1%Free cash flow margin−372.7%Fiscal year 2019Gross margin62.7%Operating margin14.1%Net margin15.6%Free cash flow margin23.6%Fiscal year 2020Gross margin34.7%Operating margin−40.6%Net margin−42.3%Free cash flow margin−35.9%Fiscal year 2021Gross margin36.9%Operating margin−47.2%Net margin−57.0%Free cash flow margin−39.6%Fiscal year 2022Gross margin49.7%Operating margin−31.5%Net margin−74.0%Free cash flow margin−47.0%Fiscal year 2023Gross margin19.1%Operating margin−81.8%Net margin−35.9%Free cash flow margin−90.6%Fiscal year 2024Gross margin13.0%Operating margin−95.9%Net margin−149.5%Free cash flow margin−98.4%Fiscal year 2025Gross margin19.2%Operating margin−149.0%Net margin−140.8%Free cash flow margin−127.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin −38.5% 36.8% 38.6% 62.7% 34.7% 36.9% 49.7% 19.1% 13.0% 19.2%
Operating margin −1,293.6% −548.4% −116.4% 14.1% −40.6% −47.2% −31.5% −81.8% −95.9% −149.0%
Net margin −1,212.1% −887.4% −31.1% 15.6% −42.3% −57.0% −74.0% −35.9% −149.5% −140.8%
Free cash flow margin −1,098.6% −701.1% −372.7% 23.6% −35.9% −39.6% −47.0% −90.6% −98.4% −127.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−16.4Capital expenditure−0.7Free cash flow−17.1Fiscal year 2017Operating cash flow−16.5Capital expenditure−1.0Free cash flow−17.5Fiscal year 2018Operating cash flow−12.2Capital expenditure−0.5Free cash flow−12.7Fiscal year 2019Operating cash flow8.3Capital expenditure−0.8Free cash flow7.5Fiscal year 2020Operating cash flow−6.9Capital expenditure−0.9Free cash flow−7.8 −204.3%Fiscal year 2021Operating cash flow−8.9Capital expenditure−0.5Free cash flow−9.4Fiscal year 2022Operating cash flow−11.9Capital expenditure−0.6Free cash flow−12.4Fiscal year 2023Operating cash flow−10.5Capital expenditure−6.5Free cash flow−16.9Fiscal year 2024Operating cash flow−13.6Capital expenditure−6.3Free cash flow−19.9Fiscal year 2025Operating cash flow−16.1Capital expenditure−5.5Free cash flow−21.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −16.4 −16.5 −12.2 8.3 −6.9 −8.9 −11.9 −10.5 −13.6 −16.1
Capital expenditure −0.7 −1.0 −0.5 −0.8 −0.9 −0.5 −0.6 −6.5 −6.3 −5.5
Free cash flow −17.1 −17.5 −12.7 7.5 −7.8 −9.4 −12.4 −16.9 −19.9 −21.6
Growth −204.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash28.9Shareholders’ equity7.8Fiscal year 2017Cash36.1Shareholders’ equity9.4Fiscal year 2018Cash6.7Shareholders’ equity9.0Fiscal year 2019Cash7.2Shareholders’ equity15.2Fiscal year 2020Cash17.4Shareholders’ equity7.3Fiscal year 2021Cash11.0Shareholders’ equity−4.6Fiscal year 2022Cash33.9Shareholders’ equity10.9Fiscal year 2023Cash11.9Shareholders’ equity31.6Fiscal year 2024Cash9.2Shareholders’ equity31.2Fiscal year 2025Cash4.8Shareholders’ equity43.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 28.9 36.1 6.7 7.2 17.4 11.0 33.9 11.9 9.2 4.8
Shareholders’ equity 7.8 9.4 9.0 15.2 7.3 −4.6 10.9 31.6 31.2 43.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1.6 2.5 3.4 31.8 21.8 23.8 26.5 18.7 20.2 17.0
Growth +60.2% +36.3% +834.7% −31.5% +9.2% +11.5% −29.5% +8.2% −16.1%
2.2 1.6 2.1 11.8 14.2 15.0 13.3 15.1 17.6 13.7
−0.6 0.9 1.3 19.9 7.5 8.8 13.2 3.6 2.6 3.3
Growth +43.0% +1,418.7% −62.2% +16.2% +50.1% −72.8% −26.4% +23.5%
7.1 5.5 4.1 5.0 7.7 10.3 10.2 7.5 8.9 14.3
4.1 3.8 3.8 5.2 5.5 6.3 6.9 6.8 8.2 8.4
−20.2 −13.7 −4.0 4.5 −8.8 −11.2 −8.3 −15.3 −19.4 −25.3
Growth −296.8%
n/a n/a n/a 2.1 −9.3 −13.5 −19.5 −6.5 −30.2 −23.7
n/a n/a n/a 0.0 0.0 0.0 0.1 0.2 0.1 0.2
−18.9 −22.1 −1.1 5.0 −9.2 −13.6 −19.6 −6.7 −30.2 −23.9
Growth −285.6%
Per share
n/a n/a n/a n/a −2.38 −3.48 −3.93 −0.75 −3.03 −2.10
n/a n/a n/a n/a −2.38 −3.48 −3.93 −0.75 −3.03 −2.10
Growth
21.9 23.3 27.1 n/a n/a 3.9 5.0 9.0 10.0 11.4
n/a 23.3 27.1 27.2 27.2 3.9 5.0 9.0 10.0 11.4
Growth +16.2% +0.2% +0.1% −85.7% +28.1% +80.7% +10.5% +14.2%

† The diluted share count jumps at 2021 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 4.9% a year over five years.
  • Operating margin is down 108.4 points on five years ago, at -149.0%.
  • A net loss in 9 of 10 years on file.